SCHEMBL18201299

SCHEMBL18201299

c1ccc(-c2cc(-c3cccc(-c4nc5ccccc5c5c4ccc4ccccc45)n3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
NTSR1 P30989 1/20 0.39
ACHE P22303 1/20 0.38
LMNA P02545 5/20 0.38
ATM Q13315 1/20 0.38
GLA P06280 1/20 0.38
PTGES O14684 1/20 0.37
NQO2 P16083 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
RECQL P46063 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200691 0.98 PTGES (0.41) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18200713 0.98 PTGES (0.41) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18200693 0.98 PTGES (0.41) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18201298 0.92 KDM4E (0.43) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18201296 0.88 MEN1 (0.43) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18200904 0.88 RAB9A (0.48) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18200848 0.87 MAPT (0.43) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18201099 0.87 MEN1 (0.48) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL17034895 0.87 MEN1 (0.48) MAPTHPGDKDM4EALDH1A1MEN1
SCHEMBL18200715 0.86 MAPT (0.42) MAPTHPGDKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885HPGD 421/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.